Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction

Clicks: 328
ID: 274047
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #2 of 2 articles by views in the journal of gene medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
For decades, mesenchymal stem (MSCs) cells have been used for cardiovascular diseases as regenerative therapy. This review is an attempt to summarize the types of MSCs involved in myocardial infarction (MI) therapy, as well as its possible mechanisms effects, especially the paracrine one in MI focus …
Reference Key
ae2017themesenchymal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shafei AE;Ali MA;Ghanem HG;Shehata AI;Abdelgawad AA;Handal HR;Talaat KA;Ashaal AE;El-Shal AS;;
Journal the journal of gene medicine
Year 2017
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.